학술논문
Synthesis, SAR, and series evolution of novel oxadiazole-containing 5-lipoxygenase activating protein inhibitors: Discovery of 2-[4-(3-{(R)-1-[4-(2-amino-pyrimidin-5-yl)-phenyl]-1-cyclopropyl-ethyl}-[1,2,4]oxadiazol-5-yl)-pyrazol-1-yl]- N, N -dimethyl-acetamide (BI 665915)
Document Type
Article
Author
Takahashi, H.; Riether, D.; Bartolozzi, A.; Bosanac, T.; Berger, V.; Binetti, R.; Chen, Z.; De Lombaert, S.; Fadra-Khan, T.; Hao, M.-H.; Huber, J.; Hutzler, J.M.; Liu, W.; Lo, H.Y.; Mahaney, P.E.; Morwick, T.M.; Olague, A.; Pack, E.; Padyana, A.K.; Thomson, D.S.; Wu, L.; Zindell, R.M.; Abeywardane, A.; Simpson, T.; Broadwater, J.; Dave, R.; Kerr, S.; Crux, R.; Dines, J.A.; Flegg, A.; Garrigou, M.; Kotey, A.; Loke, P.L.; Napier, S.; Tye, H.
Source
In: Journal of Medicinal Chemistry . (Journal of Medicinal Chemistry, 26 February 2015, 58(4):1669-1690)
Subject
Language
English
ISSN
15204804
00222623
00222623